Biochemistry, Genetics and Molecular Biology
Anura
100%
Insulin Release
87%
Skin Secretion
58%
Peptide Sequence
46%
Gastric Inhibitory Polypeptide
43%
Antimicrobial Peptides
43%
Glucagon-Like Peptide-1
39%
Glucagon
38%
Rana
29%
Host Resistance
28%
Secretion (Process)
27%
Blood Plasma
27%
Amino Acids
26%
Antimicrobial Activity
23%
Copurification
22%
Gene Expression
21%
Enzyme
21%
Methylation
21%
Minimum Inhibitory Concentration
20%
DNA Methylation
20%
Antidiabetic Activity
20%
Glucose Homeostasis
20%
Temporin
19%
Precursor
19%
Arginine
19%
Glucose Blood Level
19%
Proteomics
19%
Cell Function
18%
Adenosine Triphosphate
18%
Xenopus
18%
N-Terminus
18%
Folic Acid
17%
Body Weight
17%
Metabolic Pathway
17%
Pipidae
16%
Genotyping
16%
Genetics
16%
Agonist
15%
Biological Activity
14%
Staphylococcus Aureus
14%
Genomics
14%
Bradykinin
14%
Homocysteine
14%
Escherichia coli
13%
Peptidomics
13%
Messenger RNA
13%
C-Terminus
13%
Infectious Agent
13%
Incretin
12%
Cytotoxicity
12%
Ob/Ob Mouse
12%
Streptozotocin
12%
Vitamin D
12%
Blood Pressure
11%
Cancer Cell
11%
Methylenetetrahydrofolate Reductase
11%
Hyperglycemia
11%
Mass Spectrometry
11%
Glucagon-Like Peptide 1 Receptor
11%
Cyclic Adenosine Monophosphate
11%
Insulin Resistance
11%
LC50
11%
Receptor Antagonist
11%
Somatostatin
10%
Cladistics
10%
MicroRNA
10%
Norepinephrine
10%
Conformation
10%
Riboflavin
10%
Glucagon Receptor
10%
Epigenetics
10%
Insulin Sensitivity
10%
Prevalence
10%
Cell Proliferation
10%
Dipeptidyl Peptidase
10%
Allele
9%
Alanine
9%
Ranidae
9%
Reverse Phase High Performance Liquid Chromatography
9%
Glycation
9%
Microorganism
9%
Promoter Region
9%
Insulin Blood Level
9%
Pancreatic Polypeptide
9%
Magainin
9%
Metabolite
9%
B Vitamin
8%
Signal Transduction
8%
Gastric Inhibitory Polypeptide Receptor
8%
Gram Negative Bacterium
8%
Neuropeptide Y
8%
Immunity
8%
Skeletal Muscle
8%
Xenopus laevis
8%
Cytokine
8%
Salmonine
7%
Proteome
7%
Proinsulin
7%
Cell Membrane
7%
Normal Human
7%
Pharmacology, Toxicology and Pharmaceutical Science
Gastric Inhibitory Polypeptide
57%
Glucagon-Like Peptide-1
47%
Disease
42%
Non Insulin Dependent Diabetes Mellitus
40%
Antidiabetic Agent
39%
Anura
37%
Receptor
34%
Biosurfactant
34%
Amino Acid
27%
Antiinfective Agent
26%
Biological Marker
25%
Neoplasm
25%
Diabetes Mellitus
23%
Malignant Neoplasm
20%
Vitamin D
19%
Prostate Cancer
18%
Salmonine
18%
Folic Acid
17%
Arginine
17%
Incretin
17%
Inflammation
17%
Ob/Ob Mouse
17%
Streptozotocin
16%
Antioxidant
16%
Cytokine
15%
Microorganism
15%
Substance P
14%
Biological Activity
14%
Cytotoxicity
14%
Infectious Agent
14%
Antimicrobial Agent
14%
Gastric Inhibitory Polypeptide Receptor
13%
Homocysteine
13%
Amyotrophic Lateral Sclerosis
13%
Exendin 4
13%
Diabetic Obesity
13%
Rhamnolipid
13%
Dipeptidyl Peptidase IV
13%
Tachykinin
12%
Pseudomonas aeruginosa
12%
Alzheimer's Disease
12%
Placebo
12%
Infection
12%
Surfactant
11%
Breast Cancer
11%
Calcium Ion
11%
Bradykinin
11%
Polypeptide Antibiotic Agent
11%
Methylmercury
10%
Normal Human
10%
Prevalence
10%
Oncorhynchus mykiss
10%
Adenosine Triphosphate
10%
Mouse Model
10%
Neurokinin A
10%
Antibiotics
10%
Fatty Acid
9%
Carboxamide
9%
Glucagon-Like Peptide 1 Receptor
9%
Hemolysis
9%
Cell Viability
9%
Liraglutide
9%
Staphylococcus Aureus
9%
Colorectal Carcinoma
9%
Insulin Dependent Diabetes Mellitus
9%
Comet Assay
8%
Polyunsaturated Fatty Acid
8%
Neurotensin
8%
Adverse Event
8%
Nanoparticle
8%
Neuropeptide
8%
Clinical Trial
7%
Dogfish
7%
Hypoxia
7%
Alanine
7%
Long Term Exposure
7%
Hyperglycemia
7%
Glucagon
7%
Tumor Necrosis Factor
7%
Antibiotic Resistance
7%
Cardiovascular Disease
7%
Observational Study
7%
Combination Therapy
7%
Glaucoma
7%
Randomized Controlled Trial
7%
Polyphenol
7%
Vasoactive Intestinal Polypeptide
7%
Tolbutamide
7%
Riboflavin
7%
Escherichia coli
7%
Sulfonylurea
7%
Antioxidant Capacity
6%
High Performance Liquid Chromatography
6%
Metformin
6%
Insulin Resistance
6%
Scyliorhinus canicula
6%
Glucagon Like Peptide 1 [7-36] Amide
6%
Gram Negative Bacterium
6%
Receptor Antagonist
6%
Antibacterial Activity
6%
Medicine and Dentistry
Diabetes
52%
Gastric Inhibitory Polypeptide
45%
Disease
42%
Beta Cell
40%
Insulin Release
34%
Maturity Onset Diabetes of the Young
32%
Glucagon Like Peptide 1
32%
In Vitro
27%
Nutrition
27%
Receptor
26%
Pancreatic Islet
23%
Biological Marker
22%
Systematic Review
19%
Antidiabetic Agent
17%
Glucose Tolerance
16%
Diabetes Mellitus
15%
Prostate Cancer
15%
Incretin
14%
Cell Function
14%
Glucagon
14%
Supplementation
14%
Refractive Error
14%
Calcium Ion
13%
Neoplasm
13%
Gut
13%
Cell Line
12%
Streptozocin
12%
Gene Expression
12%
Malignant Neoplasm
12%
Vitamin D
12%
Antidiabetic Activity
12%
Randomized Controlled Trial
11%
Prevalence
11%
Meta-Analysis
11%
Drug Therapy
11%
Secretion (Process)
10%
Body Weight
10%
Amyotrophic Lateral Sclerosis
10%
Diagnosis
10%
Insulin Resistance
10%
Glucose Homeostasis
9%
High Fat Food
9%
Hyperglycemia
9%
Child Development
9%
Glaucoma
9%
Exenatide
9%
Observational Study
8%
Public Health
8%
Infection
8%
Programmed Cell Death
8%
Physical Activity
8%
Visual Acuity
8%
Cell Transdifferentiation
8%
Folic Acid
8%
Glucagon Like Peptide 1 Receptor
8%
Nutrition Physiology
8%
Riboflavin
8%
Bariatric Surgery
8%
Food Intake
8%
Placebo
8%
Insulin Dependent Diabetes Mellitus
8%
Liraglutide
8%
Propionibacterium acnes
7%
Adenosine Triphosphate
7%
Alzheimer's Disease
7%
Cross Sectional Study
7%
Hypoxia
7%
Antioxidant
7%
Gut Microbiota
7%
Diabetic Obesity
7%
Obesity
6%
Clinical Trial
6%
Body Mass Index
6%
COVID-19
6%
Optical Coherence Tomography
6%
microRNA
6%
Caloric Intake
6%
Ob/Ob Mouse
6%
Visual Impairment
6%
Polyphenol
6%
Gastrointestinal Hormone
6%
Water-Electrolyte Imbalance
6%
Nutrition Education
6%
Combination Therapy
5%
Health Outcomes
5%
Down Syndrome
5%
Amino Acid
5%
Somatostatin
5%
Cancer Cell
5%
Insulin Sensitivity
5%
Glycemic Control
5%
Signal Transduction
5%
Anterior Chamber of Eyeball
5%
Gene Therapy
5%
Blood Glucose
5%
Cardiovascular Disease
5%
Quality of Life
5%
Alanine
5%
Breast Cancer
5%
Proteomics
5%